Turinabol: Pharmacological Properties, Experimental Studies, and Clinical Applications

Abstract

Background: Turinabol (4-chlorotestosterone acetate), a synthetic anabolic steroid developed in the 1950s, has been studied for its potential therapeutic benefits in a range of medical conditions. These include muscle wasting, osteoporosis, liver diseases, and post-surgical recovery. Turinabol has a unique anabolic profile with reduced androgenic side effects compared to other anabolic steroids.

Objective: This paper aims to provide a comprehensive review of the pharmacological properties, experimental studies, and clinical applications of Turinabol, evaluating its efficacy and safety profile across various therapeutic contexts.

Methods: A systematic literature search was conducted using academic databases, including PubMed, Scopus, and Google Scholar, to identify experimental studies and clinical trials published between the 1950s and 1970s. A total of 48 references were included, with 25 experimental studies and 23 clinical trials.

Results: Experimental studies demonstrated that Turinabol enhances protein synthesis, nitrogen retention, and tissue hypertrophy, especially in muscle, heart, and liver tissues. Clinical trials showed its positive effects in promoting weight gain, muscle growth, and bone health, particularly in pediatric and post-surgical populations.

Conclusion: Turinabol has shown considerable efficacy in treating conditions involving muscle wasting, delayed growth, and tissue recovery, particularly in pediatric and post-surgical settings. Its reduced androgenic side effects make it suitable for both male and female patients, although careful monitoring is necessary due to the risk of liver toxicity, especially with long-term use. Despite the decline in clinical use as newer anabolic steroids emerged, Turinabol remains an important historical example of early anabolic steroid development with therapeutic applications in diverse medical conditions.

Keywords: Turinabol; Anabolic Steroids; Muscle Wasting; Osteoporosis; Pediatric Growth Disorders; Pharmacokinetics; Clinical Applications

Citation

Aamir Jalal Al-Mosawi. Turinabol: Pharmacological Properties, Experimental Studies, and Clinical Applications. WebLog J Pharmacol Ther. wjpt.2026.f2606. https://doi.org/10.5281/zenodo.21310176